Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1101221 | 1.00 | TSHR (0.43) | TSHRLMNAALDH1A1SMN1; SMN2CHRM1 | |
| SCHEMBL25767160 | 0.97 | TSHR (0.41) | TSHRLMNAALDH1A1SMN1; SMN2CHRM1 | |
| SCHEMBL13195682 | 0.90 | — | — | |
| SCHEMBL33592 | 0.90 | — | — | |
| SCHEMBL15804715 | 0.90 | — | — | |
| SCHEMBL322738 | 0.89 | ALDH1A1 (0.54) | TSHRLMNAALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL17526930 | 0.89 | ALDH1A1 (0.43) | TSHRLMNAALDH1A1SMN1; SMN2CHRM1 | |
| SCHEMBL9156073 | 0.89 | ALDH1A1 (0.43) | TSHRLMNAALDH1A1SMN1; SMN2CHRM1 | |
| SCHEMBL15187318 | 0.88 | — | — | |
| SCHEMBL15187340 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10836976-B2 | Polymeric viscosity modifiers for use in lubricants | AFTON CHEMICAL CORPORATION (US) | 2020-11-17 | — | — | US | claimed |
| US-9688838-B1 | Diisononyl terephthalate plasticizer and its use as well as process for producing the same | NAN YA PLASTICS CORPORATION (TW) | 2017-06-27 | — | — | US | claimed |
| US-20260130860-A1 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | FLAGSHIP LABS 114, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4735417-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | Shanghai Vitalgen Biopharma Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| EP-4368662-B1 | POLYAMIDE-IMIDE-BASED FILM, PROCESS FOR PREPARING THE SAME, AND COVER WINDOW AND DISPLAY DEVICE COMPRISING THE SAME | SK MICROWORKS SOLUTIONS CO LTD (KR) | 2025-12-24 | — | — | EP | disclosed |
| US-12312293-B2 | Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents | MODERNATX, INC. (US) | 2025-05-27 | — | — | US | disclosed |
| WO-2025000542-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | SHANGHAI VITALGEN BIOPHARMA CO., LTD. (CN) | 2025-01-02 | — | — | WO | disclosed |
| WO-2025002399-A1 | IONIZABLE CATIONIC LIPID COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | SHANGHAI VITALGEN BIOPHARMA CO., LTD. (CN) | 2025-01-02 | — | — | WO | disclosed |
| US-20240174825-A1 | POLYAMIDE-IMIDE-BASED FILM, PROCESS FOR PREPARING THE SAME, AND COVER WINDOW AND DISPLAY DEVICE COMPRISING THE SAME | MICROWORKS SOLUTIONS CO., LTD. (KR) | 2024-05-30 | — | — | US | disclosed |
| EP-4368662-A1 | POLYAMIDE-IMIDE-BASED FILM, PROCESS FOR PREPARING THE SAME, AND COVER WINDOW AND DISPLAY DEVICE COMPRISING THE SAME | SK microworks Co., Ltd. (KR) | 2024-05-15 | — | — | EP | disclosed |
| CN-118027668-A | Polyamide-imide-based film, method of preparing the same, and cover window and display device including the same | 爱思开迈克沃有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-7838533-B2 | Azaindole inhibitors of MTP and ApoB | MERCK PATENT GMBH (DE) | 2010-11-23 | — | — | US | disclosed |
| CN-101878193-A | Bicyclic gamma-amino acid derivatives | DAIICHI SANKYO CO LTD | 2010-11-03 | — | — | CN | disclosed |
| US-7557111-B2 | Substituted thieno[3,2-d]pyrimidines as CRF receptor antagonists | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2009-07-07 | — | — | US | disclosed |
| US-20090036481-A1 | Novel Azaindole Inhibitors of Mtp and Apob | MERCK PATENT GMBH (DE) | 2009-02-05 | — | — | US | disclosed |
| EP-1771446-B1 | AZAINDOLE INHIBITORS OF MTP AND APOB | MERCK PATENT GMBH (DE) | 2008-06-11 | — | — | EP | disclosed |
| US-20070254898-A1 | Thienopyrimidine and Thienopyridine Derivatives Substituted with Cyclic Amino Group | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-11-01 | — | — | US | disclosed |
| US-6888030-B2 | Advances in amination | HUNTSMAN PETROCHEMICAL CORPORATION (US) | 2005-05-03 | — | — | US | disclosed |
| US-20030078344-A1 | Advances in amination | HUNTSMAN PETROCHEMICAL CORPORATION | 2003-04-24 | — | — | US | disclosed |
| US-4246282-A | ω-Dialkylalkanoic acid derivatives used to induce antianoxic activity | LABAZ (FR) | 1981-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254898-A1 | Thienopyrimidine and Thienopyridine Derivatives Substituted with Cyclic Amino Group | HRH2, HRH3, HRH4 | TSHR 125/4885LMNA 4519/4885ALDH1A1 3445/4885 |
| US-20090036481-A1 | Novel Azaindole Inhibitors of Mtp and Apob | APOB, MTPN, HDLBP | TSHR 1887/4885LMNA 1279/4885ALDH1A1 3630/4885 |
| US-12312293-B2 | Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents | PLTP, LNPK, PLIN3 | TSHR 2764/4885LMNA 712/4885ALDH1A1 4727/4885 |
| US-20260130860-A1 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | NSUN3, NSUN2, LDLR | TSHR 545/4885LMNA 224/4885ALDH1A1 4164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.